Literature DB >> 18365878

Different pattern of pleiotrophin and midkine expression in neuropathic pain: correlation between changes in pleiotrophin gene expression and rat strain differences in neuropathic pain.

Laura Ezquerra1, Luis F Alguacil, Trang Nguyen, Thomas F Deuel, Inmaculada Silos-Santiago, Gonzalo Herradon.   

Abstract

Pleiotrophin (PTN) and midkine (MK) are two growth factors highly redundant in function that exhibit neurotrophic actions and are upregulated at sites of nerve injury, both properties being compatible with a potential involvement in the pathophysiological events that follow nerve damage (i.e. neuropathic pain). We have tested this hypothesis by comparatively studying PTN and MK gene expression in the spinal cord and dorsal root ganglia (DRG) of three rat strains known to differ in their behavioural responses to chronic constriction injury (CCI) of the sciatic nerve: Lewis, Fischer 344 (F344) and Sprague-Dawley (SD). Real time RT-PCR revealed minimal changes in PTN/MK gene expression in the spinal cord after CCI despite the strain considered, but marked changes were detected in DRG. A significant upregulation of PTN gene expression occurred in injured DRG of the F344 strain, the only strain that recovers from CCI-induced mechanical allodynia 28 days after surgery. In contrast, PTN was found to be downregulated in injured DRG of SD rats, the most sensitive strain in behavioural studies. These changes in PTN were not paralleled by concomitant modifications of MK gene expression. The results demonstrate previously unidentified differences between PTN and MK patterns of expression. Furthermore, the data suggest that upregulation of PTN, but not MK, could play an important role in the recovery from CCI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365878     DOI: 10.1080/08977190801987711

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  5 in total

1.  Pleiotrophin regulates microglia-mediated neuroinflammation.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Esther Gramage; Jimena Pita; Carmen Pérez-García; Marcel Ferrer-Alcón; María Uribarri; María P Ramos; Gonzalo Herradón
Journal:  J Neuroinflammation       Date:  2017-03-04       Impact factor: 8.322

2.  Genetic polymorphism of pleiotrophin is associated with pain experience in Japanese adults: Case-control study.

Authors:  Kosuke Saita; Masahiko Sumitani; Daisuke Nishizawa; Takashi Tamura; Kazutaka Ikeda; Kenji Wakai; Yoshika Sudo; Hiroaki Abe; Jun Otonari; Hiroaki Ikezaki; Kenji Takeuchi; Asahi Hishida; Keitaro Tanaka; Chisato Shimanoe; Toshiro Takezaki; Rie Ibusuki; Isao Oze; Hidemi Ito; Etsuko Ozaki; Daisuke Matsui; Yohko Nakamura; Miho Kusakabe; Sadao Suzuki; Hiroko Nakagawa-Senda; Kokichi Arisawa; Sakurako Katsuura-Kamano; Kiyonori Kuriki; Yoshikuni Kita; Yasuyuki Nakamura; Yukihide Momozawa; Kanji Uchida
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

3.  Differential neuropathic pain sensitivity and expression of spinal mediators in Lewis and Fischer 344 rats.

Authors:  Glenn-Marie Le Coz; Cathy Fiatte; Fernand Anton; Ulrike Hanesch
Journal:  BMC Neurosci       Date:  2014-02-28       Impact factor: 3.288

4.  Intrathecal leptin inhibits expression of the P2X2/3 receptors and alleviates neuropathic pain induced by chronic constriction sciatic nerve injury.

Authors:  Xin Li; Lumei Kang; Guilin Li; Huihong Zeng; Lei Zhang; Xiang Ling; Hui Dong; Shangdong Liang; Hongping Chen
Journal:  Mol Pain       Date:  2013-12-10       Impact factor: 3.395

5.  Leptin Contributes to Neuropathic Pain via Extrasynaptic NMDAR-nNOS Activation.

Authors:  Yanling Liang; Yuxin Ma; Jieqin Wang; Lei Nie; Xusheng Hou; Wenyu Wu; Xingmei Zhang; Yinghong Tian
Journal:  Mol Neurobiol       Date:  2020-10-25       Impact factor: 5.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.